HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Intermediate Filament Proteins

Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein.
Also Known As:
Filament Proteins, Intermediate; Proteins, Intermediate Filament; Fibroblast Intermediate Filament Proteins
Networked: 235 relevant articles (3 outcomes, 26 trials/studies) for this Bio-Agent, Comments

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pekny, Milos: 5 articles (01/2010 - 05/2004)
2. Wilhelmsson, Ulrika: 4 articles (01/2010 - 05/2004)
3. Li, Lizhen: 3 articles (10/2007 - 05/2004)
4. Pekna, Marcela: 2 articles (01/2010 - 05/2004)
5. Sihlbom, Carina: 2 articles (10/2007 - 09/2007)
6. Miettinen, Markku: 2 articles (01/2006 - 06/2002)
7. Zou, Zhongju: 1 article (11/2012)
8. Xiao, Guanghua: 1 article (11/2012)
9. White, Michael: 1 article (11/2012)
10. Wei, Yongjie: 1 article (11/2012)

Related Diseases

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
3. Gliosis
06/01/2005 - "Particular emphasis is placed on the lessons learnt from mouse genetic models in which the absence of intermediate filament proteins in astrocytes leads to attenuation of reactive gliosis with distinct pathophysiological and clinical consequences."
12/01/2005 - "Neuronal intermediate filament inclusion disease (NIFID) is a new neurodegenerative disease characterized histologically by the presence of neuronal cytoplasmic inclusions (NI) immunopositive for intermediate filament proteins, neuronal loss, swollen achromatic neurons (SN), and gliosis. "
01/01/2010 - "Adult mice lacking the intermediate filament proteins GFAP and vimentin (GFAP(-/-)Vim(-/-)) show attenuated reactive gliosis, reduced glial scar formation and improved regeneration of neuronal synapses after neurotrauma. "
09/01/2007 - "2D-gel electrophoresis and mass spectrometry were applied to study the proteome difference in denervated hippocampus in wildtype mice and mice lacking intermediate filament proteins glial fibrillary acidic protein (GFAP) and vimentin (GFAP-/-Vim-/-) that show attenuated reactive gliosis and enhanced posttraumatic regeneration. "
02/01/2011 - "Neuronal intermediate filament inclusion disease (NIFID), a rare form of frontotemporal lobar degeneration (FTLD), is characterized neuropathologically by focal atrophy of the frontal and temporal lobes, neuronal loss, gliosis, and neuronal cytoplasmic inclusions (NCI) containing epitopes of ubiquitin and neuronal intermediate filament proteins. "
Order ALL the reference details at left...
4. Cicatrix (Scar)
5. Glioma (Gliomas)

Related Drugs and Biologics

1. Vimentin
2. Monoclonal Antibodies
3. Keratins (Keratin)
4. Glial Fibrillary Acidic Protein
5. nestin (nestin protein)
6. Antibodies
7. Desmin
8. Proteins (Proteins, Gene)
9. Paraffin
10. peripherin

blog comments powered by Disqus
TREATMENT OPTIONS
for Neoplasms,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 25767 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>